Steven Cohen Charles River Laboratories International, Inc. Transaction History

Point72 Asset Management, L.P.

$44.6 Billion
Q2 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 236,408 shares of CRL stock, worth $44.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

236,408

Holding current value

$44.5 Million

% of portfolio

0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$99.75 - $151.89 $23.6 Million - $35.9 Million	236,408 New	236,408 $35.9 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $50.6 Million - $73.4 Million	307,398 Added 499.14%	368,984 $87.2 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $37.6 Million - $42.1 Million	-193,592 Reduced 75.87%	61,586 $12.1 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $46.9 Million - $53.7 Million	255,178 New	255,178 $53.7 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $36 Million - $49.5 Million	197,387 Added 1360.07%	211,900 $41.7 Million
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $13.1 Million - $19.4 Million	-64,148 Reduced 81.55%	14,513 $3.11 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $449,953 - $637,675	1,761 Added 2.29%	78,661 $22.3 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $22.5 Million - $28.7 Million	64,006 Added 496.4%	76,900 $29 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $12.1 Million - $14.9 Million	-32,587 Reduced 71.65%	12,894 $5.32 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $31.9 Million - $40.3 Million	-108,541 Reduced 70.47%	45,481 $16.8 Million
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $20.9 Million - $25.1 Million	83,770 Added 119.24%	154,022 $44.6 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $3.73 Million - $4.24 Million	16,780 Added 31.38%	70,252 $17.6 Million
Q3 2020 Nov 16, 2020	BUY	$175.56 - $226.45 $9.39 Million - $12.1 Million	53,472 New	53,472 $12.1 Million
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $31 Million - $49.4 Million	-260,500 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $10.2 Million - $18.5 Million	103,628 Added 66.06%	260,500 $32.9 Million
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $18.3 Million - $22.1 Million	144,949 Added 1215.71%	156,872 $24 Million
Q3 2019 Nov 15, 2019	BUY	$125.07 - $143.67 $1.43 Million - $1.64 Million	11,423 Added 2284.6%	11,923 $1.58 Million
Q2 2019 Aug 14, 2019	BUY	$123.4 - $148.55 $61,700 - $74,275	500 New	500 $71,000
Q1 2019 May 15, 2019	SELL	$104.82 - $146.73 $32.2 Million - $45.1 Million	-307,600 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$105.09 - $137.23 $32.3 Million - $42.2 Million	307,600 New	307,600 $34.8 Million

Others Institutions Holding CRL

# of Institutions

622

Shares Held

52.5M

Call Options Held

1.42M

Put Options Held

1.42M

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.58B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account